Abyssinia Bio, Inc.
- Biotech or pharma, therapeutic R&D
- Diagnostics
Abyssinia Bio is on a mission to eradicate Alzheimer's disease and other neurodegenerative diseases through our precision targeting of toxic protein aggregates. Current pipeline includes our Aβ oligomer specific immunoassay and monoclonal antibodies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}